House passes new user-fee bill; UCB snaps up majority stake in Brazil's Meizler;

@FiercePharma: Icahn's back after Forest Labs, plans to nominate board candidates, including crony Eric Ende--BW. News | Follow @FiercePharma

> The U.S. House passed the FDA user-fee bill, which revamps device approvals and aims to speed up drug approvals, putting it in line for reconciliation with the Senate version. News

> Belgium's UCB has nabbed a majority stake in Brazil's Meizler Biopharma to expand its penetration in emerging markets, with an option to buy the rest of the company later. Report

> Pfizer ($PFE) prevailed in another liability lawsuit over its hormone therapy Prempro; a jury found that the company's Wyeth unit properly warned patients about the risks of the drug. Story

> Valeant Pharmaceuticals ($VRX) CEO Michael Pearson says he's aiming to grow the company in emerging and niche markets that Big Pharma isn't focusing on. Report

> Former Merck Serono CEO Elmar Schnee is joining the board of Swiss tech firm Anecova. Item

Biotech News

@FierceBiotech: NIH group to award up to $20B in IT contracts. News | Follow @FierceBiotech

@JohnCFierce: Lilly still building its data on Livalo (statin) compared to Pravachol. Are they making any sales yet? Tough biz. Release | Follow @JohnCFierce

@RyanMFierce: After Stiefel/GSK deal, Canadian biotech Welichem's shares slide 18.75%, or CAD 9 cents. More | Follow @RyanMFierce

> Sanofi R&D chief spotlights diabetes strategy amid Amylin bid buzz. Story

> Chelsea scuttles rheumatoid arthritis drug after PhII failure, shares dive. Article

> House stamps approval on fast-track approach to drug development. More

Medical Devices News

@FierceMedDev: An ex-Spectranetics CEO gets a year's probation for lying to the feds. Story | Follow @FierceMedDev

@MarkHFierce: Could the VA's plan to streamline spending on prosthetics hurt device companies? Article | Follow @MarkHFierce

> Affymetrix, Leica to launch automated Dx/Rx research tool. More

> VA looks to streamline prosthetic spending. Story

> U.S. House passes $6.4 billion user fee reauthorization bill. Report

> GE Healthcare moves to develop lung cancer Dx. News

CRO News

 @NesaNFierce: Frazier Healthcare will buy Catalent's Philly and Woodstock, IL, commercial packaging ops, but both parties are mum on the deal's cost. More | Follow @NesaNFierce

> Creditors file $80M bid for financially strapped Cetero. Article

> New CRO Agility Clinical to focus on pediatric and orphan diseases. Story

> CMO revenue expected to double in Europe in 6 years. Item

> Covance, Bayer Healthcare enter strategic R&D partnership. News

Pharma Manufacturing News

> Another Indian drugmaker expanding in Nigeria. Item

> Fake Adderall surfaces as Congress turns attention to track and trace. More

> China's Biostar says it has replaced 5M tainted capsules. News

> FDA spanks J&J McNeil plant over complaint failures. Article

Vaccines News

> Bionor's new HIV vaccine moves into clinical trials. News

> Oral TB vax could cut treatment time. More

> Making safer and better shots. Story

> Merck's RotaTeq will be saving lives in Rwanda. Item

And Finally... Bariatric surgery may fight diabetes in other ways besides promoting weight loss. Article

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.